Financials

News Discussions Technicals Forecast Seasonals

688278 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Xiamen Amoytop Biotech Co. Ltd. engages in the research and development of genetic engineering technology. It develops recombinant protein drugs such as rHuGM-CSF, rHuG-CSF, rHuIL-11, rHuIFN a-2a and rHuIFN a-2b.The company's products include Molgramostim, Filgrastim, and Oprelvekin. Xiamen Amoytop Biotech was founded on August 7, 1996 and is headquartered in Xiamen, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

688278 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company